Cardiff Oncology resolves Nerviano litigation, amends onvansertib license
Cardiff Oncology said it settled its dispute with Nerviano Medical Sciences through a confidential settlement and amended the onvansertib license. The settlement calls for dismissal of the litigation with prejudice, mutual releases, and no admission of liability or monetary payments, according to the company’s statement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.